1. Guided selection of antiplatelet therapy reduced rates of major adverse cardiovascular event rates compared to standard therapy.
2. Guided selection strategy was beneficial for both escalation and de-escalation of standard therapy, balancing patient-dependent ischemic and bleeding risks.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Patients who undergo percutaneous coronary intervention (PCI)...
1. Risk of recurrent stroke within 90 days of an index event was comparable among patients with non-consensus TIA and classic TIA.
2. Patients with non-consensus TIA were less likely to seek medical attention after the index event.
Evidence Rating Level: 2 (Good)
Study Rundown: The risk of stroke following a transient...